Equest Oral Gel

£19.90 (exc VAT)

£23.88 (inc VAT)

For the treatment and control of adult and larval stages of important internal parasites including encysted inhibited EL3 and developing intramucosal L4 larval stages of small redworms, arterial stages of large redworms and bots in horses and ponies with a single dose.  This clear gel contains 18.92 mg/g moxidectin and 37.84 mg/g benzyl alcohol and 0.24 mg/g disodium edetate as preservatives. Moxidectin is a second generation macrocyclic lactone of the milbemycin family.

Used at the recommended dosage level of 400 mcg moxidectin per kg bodyweight, Equest Oral Gel provides effective control of moxidectin sensitive strains of many parasites of horses and ponies. One 12.2g syringe contains sufficient gel to treat one 575 kg horse at the recommended dose rate (0.4 mg moxidectin per kg bodyweight). Each graduation on the calibrated syringe delivers sufficient gel to treat 25 kg bodyweight. 

Withdrawal period: 32 days

Legal Category: POM-VPS

Size: 12.2g

NOAH datasheet

For the most up to date information about this product please look up the Summary of Product Characteristics (SPC) on the VMD webpage Product Information Database.

£19.90 (exc VAT)

POM-VPS

Qty:

Related Products